Megan Robertson, Senior Counsel in the Health Care & Life Sciences practice, in the firm’s Washington, DC, office, quoted in Law360 Healthcare Authority, in “FDA and CMS Leaders Unite Over Proposed Lab Test Rule,” by Beth JoJack. (Read the full version – subscription required.)

Following is an excerpt:

Leaders at the U.S. Food and Drug Administration and the Centers for Medicare & Medicaid Services joined forces on Thursday, stressing that the two agencies are on the same page regarding the FDA providing increased oversight of laboratory developed tests, or LDTs. …

In a joint statement, Dr. Jeff Shuren, director of the FDA's Center for Devices and Radiological Health, and Dr. Dora Hughes, acting chief medical officer and acting director of the Center for Clinical Standards and Quality at CMS, emphasized that CMS supports the FDA's proposed rule that would allow that agency to regulate LDTs.

"Both CMS and the FDA believe that patients and their doctors need to know that LDTs are valid," Shuren and Hughes said in the statement.

For those who follow the ins and outs of the FDA, the statement was an attention-getter.

Megan Robertson, senior counsel at Epstein Becker Green, quickly posted the missive for her LinkedIn followers to see.

The interesting part of the joint statement wasn't that it provided new information about how the FDA will regulate LDTs in the future, she told Law360 on Thursday. "It's more like FDA is almost adding another stake in its defense of its position by getting CMS on board with its proposed rule," she said. …

Although the joint statement focuses on how the two agencies support the proposed rule, Robertson said it also serves as a "subtle reminder" to industry leaders that, if finalized, the rule might affect reimbursement for LDTs.

"Not to read too much into the weeds, but we try to kind of anticipate all the possible ripple effects," she said.

Jump to Page

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.